Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: October 7, 2019

PharmAust Receives R&D Tax Rebate Pre-Approval

News & Announcements 2019By Richard Mollard October 7, 2019

191007_PharmAust Receives R&D Tax Rebate Preapproval

Recent Articles

14 September, Shareholder Update
September 14, 2020
Elanco not to Exercise Agreed Option
September 9, 2020
Monepantel Anti-Covid-19 Activity Confirmed
September 9, 2020
August 31, Top 20 Shareholders
September 1, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

Epichem @epichem·

We can assure you the highest quality product for our #ReferenceMaterials production & testing, which are accredited to the highest achievable recognised international standards #ISO17034 & #ISO17025. And we’re proud of our quality management system: certified to #ISO9001.

Reply on Twitter 1305715473431097345 Retweet on Twitter 13057154734310973452 Like on Twitter 13057154734310973454 Twitter 1305715473431097345

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions